TFS
BMY icon

Thoroughbred Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Thoroughbred Financial Services’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
26,001
+22,190
+582% +$1.29M 0.09% 208
2025
Q4 		$205K Sell
3,811
-8,716
-70% -$419K 0.01% 558
2025
Q3 		$564K Sell
12,527
-280
-2% -$13.1K 0.03% 362
2025
Q2 		$592K Sell
12,807
-6,507
-34% -$319K 0.04% 343
2025
Q1 		$1.18M Buy
19,314
+1,551
+9% +$90.4K 0.07% 261
2024
Q4 		$1M Buy
17,763
+190
+1% +$10.6K 0.06% 281
2024
Q3 		$909K Buy
17,573
+7,220
+70% +$339K 0.06% 292
2024
Q2 		$430K Buy
10,353
+901
+10% +$40.3K 0.03% 409
2024
Q1 		$512K Sell
9,452
-13,643
-59% -$695K 0.05% 284
2023
Q4 		$1.19M Buy
23,095
+1,065
+5% +$55.9K 0.1% 207
2023
Q3 		$1.28M Buy
22,030
+8,217
+59% +$503K 0.13% 177
2023
Q2 		$883K Sell
13,813
-1,765
-11% -$118K 0.12% 183
2023
Q1 		$1.08M Buy
15,578
+943
+6% +$66.5K 0.16% 146
2022
Q4 		$1.05M Buy
14,635
+1,139
+8% +$85.9K 0.17% 144
2022
Q3 		$959K Hold
13,496
– – 0.18% 135
2022
Q2 		$1.04M Buy
13,496
+3,483
+35% +$265K 0.19% 130
2022
Q1 		$731K Buy
10,013
+2,939
+42% +$197K 0.12% 173
2021
Q4 		$441K Sell
7,074
-767
-10% -$45K 0.09% 212
2021
Q3 		$463K Buy
7,841
+245
+3% +$16.1K 0.11% 181
2021
Q2 		$508K Sell
7,596
-254
-3% -$16.6K 0.13% 170
2021
Q1 		$495K Buy
7,850
+1,718
+28% +$107K 0.14% 160
2020
Q4 		$380K Sell
6,132
-926
-13% -$56.9K 0.12% 168
2020
Q3 		$425K Buy
7,058
+90
+1% +$5.42K 0.16% 143
2020
Q2 		$410K Sell
6,968
-574
-8% -$34.3K 0.17% 140
2020
Q1 		$420K Buy
7,542
+1
+0% +$61 0.15% 153
2019
Q4 		$484K Sell
7,541
-125
-2% -$7.16K 0.16% 154
2019
Q3 		$389K Sell
7,666
-160
-2% -$7.52K 0.15% 161
2019
Q2 		$355K Sell
7,826
-2,053
-21% -$95.6K 0.13% 142
2019
Q1 		$471K Sell
9,879
-1,098
-10% -$54.7K 0.19% 129
2018
Q4 		$570K Buy
+10,977
New +$590K 0.28% 90

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Thoroughbred Financial Services's BMY Position: Q1 2026 in Review

Thoroughbred Financial Services increased its Bristol-Myers Squibb (BMY) stake by 582% in Q1 2026, buying an estimated $1.29M and bringing the position to 26,001 shares worth $1.58M. The position accounts for 0.09% of the portfolio, ranked #208.

Thoroughbred Financial Services first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Thoroughbred Financial Services held 26,001 shares of Bristol-Myers Squibb worth $1.58M as of Q1 2026.
  • Thoroughbred Financial Services bought 22,190 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.29M.
  • Bristol-Myers Squibb made up 0.09% of Thoroughbred Financial Services's portfolio in Q1 2026, its #208 holding.
  • Thoroughbred Financial Services first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Thoroughbred Financial Services's 13F filing for Q1 2026, filed 12 May 2026.